Skip to main content
Log in

Comparison of Approaches to Determining N-Nitrosodimethylamine Impurity in Valsartan Drug Substance By GC-MS Methods

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Methods for determining the genotoxic impurity N-nitrosodimethylamine (NDMA) in valsartan drug substance by gas chromatography (GC) with mass-spectrometric detection in SIM and MRM modes using direct introduction and vapor-phase analysis are compared. The obtained LOQ and DL differed insignificantly. The test results led to the conclusion that use of a method corresponding to the capabilities and equipment of the laboratory was advisable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. A. R. Looker, M. P. Ryan, B. J. Neubert-Langille, and R. Naji, Org. Process Res. Dev., 14(4), 1032 – 1036 (2010).

    Article  CAS  Google Scholar 

  2. O. A. Matveeva and E. L. Kovaleva, Khim.-farm. Zh., 49(11), 41 – 48 (2015).

    Google Scholar 

  3. Z. Liu, H. Fan, Y. Zhou, et al., J. Pharm. Biomed. Anal., 168, 23 – 29 (2019).

    Article  CAS  Google Scholar 

  4. Y. Huang, H. Lu, F. Zhang, and C. Min, J. Sep. Sci., 41(21), 3985 – 3994 (2018).

    Article  CAS  Google Scholar 

  5. FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity; https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm613532.htm.

  6. Combined Direct Injection N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Impurity Assay by GC/MS; https: //www.fda.gov/downloads/Drugs/DrugSafety/UCM623578.pdf [https: // www.fda.gov/media/117807/download].

  7. M. K. Parr and J. F. Joseph, J. Pharm. Biomed. Anal., 164, 536 – 549 (2019).

    Article  CAS  Google Scholar 

  8. SP RF XIVth Ed., Introduction. General Provisions. Drug Analysis Methods. GPM. 1.1.0012.15.

  9. GC/MS Headspace Method for Detection of NDMA in Valsartan Drug Substance and Drug Products; https: //www.fda.gov/downloads/Drugs/DrugSafety/UCM618053.pdf.

  10. Combined Headspace N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), and N-Nitrosodiisopropylamine (NDIPA) Impurity Assay by GC-MS/MS; https: // www.fda.gov/media/124025/download.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. D. Khorol’skii.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 53, No. 8, pp. 53 – 58, August, 2019.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khorol’skii, M.D., Anan’ina, O.V., Chaplenko, A.A. et al. Comparison of Approaches to Determining N-Nitrosodimethylamine Impurity in Valsartan Drug Substance By GC-MS Methods. Pharm Chem J 53, 766–770 (2019). https://doi.org/10.1007/s11094-019-02076-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-019-02076-y

Keywords

Navigation